Principia Wealth Advisory, LLC Atai Life Sciences N.V. Transaction History
Principia Wealth Advisory, LLC
- $104 Billion
- Q1 2025
A detailed history of Principia Wealth Advisory, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Principia Wealth Advisory, LLC holds 4,267 shares of ATAI stock, worth $6,272. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,267Holding current value
$6,272% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
105Shares Held
16.3MCall Options Held
367KPut Options Held
69.2K-
Morgan Stanley New York, NY3.33MShares$4.9 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$2.85 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.92 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$1.44 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$1.4 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $244M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...